fbpx
August 5, 2022

CV Admissions on the Rise in Americans With Cancer CV Admissions on the Rise in Americans With Cancer

Although cardiovascular disease (CVD) is known to often strike the mortal blow in patients with cancer, a national analysis puts in stark relief the burden of […]
August 5, 2022

Cognitive Rehab May Help Older Adults Clear COVID Brain Fog Cognitive Rehab May Help Older Adults Clear COVID Brain Fog

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Eight months after falling ill with covid-19, the 73-year-old woman couldn’t remember […]
August 5, 2022

Negative Antiamyloid Drug Trial: Lessons Learned Negative Antiamyloid Drug Trial: Lessons Learned

The investigational antiamyloid monoclonal antibody crenezumab (Genentech) is not superior to placebo for change in cognition, brain imaging, or biomarker outcomes in individuals who are at […]
August 5, 2022

Increasing Data Link ME/CFS, Long COVID, and Dysautonomia Increasing Data Link ME/CFS, Long COVID, and Dysautonomia

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Emerging evidence is shedding light on the common underlying mechanisms contributing to […]
August 5, 2022

Long COVID Doubles Risk of Serious Outcomes in Children, Teens Long COVID Doubles Risk of Serious Outcomes in Children, Teens

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. CDC researchers report that children and teenagers with long COVID have about […]
August 5, 2022

Just Add Water: A Biodegradable Battery for Medical Devices Just Add Water: A Biodegradable Battery for Medical Devices

Single-use electronics, such as point-of-care diagnostic devices, may become more environmentally friendly thanks to an experimental water-activated, biodegradable battery. In standard batteries, water can cause a short […]
August 5, 2022

FDA Okays Tablet Version of Acalabrutinib for All Indications FDA Okays Tablet Version of Acalabrutinib for All Indications

The US Food and Drug Administration has approved AstraZeneca’s new tablet formulation of acalabrutinib (Calquence) for all current indications of the capsule version. These include adult […]
August 5, 2022

FDA Okays First Targeted Agent for HER2-Low Breast Cancer FDA Okays First Targeted Agent for HER2-Low Breast Cancer

The US Food and Drug Administration (FDA) has approved trastuzumab deruxtecan (Enhertu) for the treatment of patients with unresectable or metastatic HER2-low breast cancer. AstraZeneca’s IV […]
August 5, 2022

Is Lp(a) a Marker for Aortic Calcium Onset? Is Lp(a) a Marker for Aortic Calcium Onset?

Lipoprotein(a) has long been thought to be a potential marker of aortic valve disease, and the population-based Rotterdam Study in the Netherlands has reported that Lp(a) […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0